vs

Side-by-side financial comparison of AMBARELLA INC (AMBA) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $108.5M, roughly 1.4× AMBARELLA INC). GLAUKOS Corp runs the higher net margin — 6.2% vs -13.9%, a 20.2% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 31.2%). Over the past eight quarters, AMBARELLA INC's revenue compounded faster (45.0% CAGR vs 25.4%).

Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

AMBA vs GKOS — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.4× larger
GKOS
$150.6M
$108.5M
AMBA
Growing faster (revenue YoY)
GKOS
GKOS
+10.0% gap
GKOS
41.2%
31.2%
AMBA
Higher net margin
GKOS
GKOS
20.2% more per $
GKOS
6.2%
-13.9%
AMBA
Faster 2-yr revenue CAGR
AMBA
AMBA
Annualised
AMBA
45.0%
25.4%
GKOS

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
AMBA
AMBA
GKOS
GKOS
Revenue
$108.5M
$150.6M
Net Profit
$-15.1M
$9.4M
Gross Margin
59.6%
77.9%
Operating Margin
-15.0%
9.0%
Net Margin
-13.9%
6.2%
Revenue YoY
31.2%
41.2%
Net Profit YoY
37.2%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBA
AMBA
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$108.5M
$143.1M
Q3 25
$95.5M
$133.5M
Q2 25
$85.9M
$124.1M
Q1 25
$84.0M
$106.7M
Q4 24
$82.7M
$105.5M
Q3 24
$63.7M
$96.7M
Q2 24
$54.5M
$95.7M
Net Profit
AMBA
AMBA
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$-15.1M
$-133.7M
Q3 25
$-20.0M
$-16.2M
Q2 25
$-24.3M
$-19.7M
Q1 25
$-20.2M
$-18.1M
Q4 24
$-24.1M
$-33.6M
Q3 24
$-34.9M
$-21.4M
Q2 24
$-37.9M
$-50.5M
Gross Margin
AMBA
AMBA
GKOS
GKOS
Q1 26
77.9%
Q4 25
59.6%
-1.1%
Q3 25
58.9%
78.4%
Q2 25
60.0%
78.3%
Q1 25
60.0%
77.2%
Q4 24
60.6%
72.9%
Q3 24
60.8%
76.6%
Q2 24
60.9%
76.4%
Operating Margin
AMBA
AMBA
GKOS
GKOS
Q1 26
9.0%
Q4 25
-15.0%
-97.7%
Q3 25
-23.0%
-12.3%
Q2 25
-30.1%
-18.3%
Q1 25
-30.2%
-19.4%
Q4 24
-30.9%
-27.2%
Q3 24
-56.9%
-25.5%
Q2 24
-72.4%
-31.3%
Net Margin
AMBA
AMBA
GKOS
GKOS
Q1 26
6.2%
Q4 25
-13.9%
-93.4%
Q3 25
-20.9%
-12.2%
Q2 25
-28.3%
-15.8%
Q1 25
-24.1%
-17.0%
Q4 24
-29.1%
-31.8%
Q3 24
-54.8%
-22.1%
Q2 24
-69.6%
-52.8%
EPS (diluted)
AMBA
AMBA
GKOS
GKOS
Q1 26
Q4 25
$-0.35
$-2.34
Q3 25
$-0.47
$-0.28
Q2 25
$-0.58
$-0.34
Q1 25
$-0.48
$-0.32
Q4 24
$-0.58
$-0.56
Q3 24
$-0.85
$-0.39
Q2 24
$-0.93
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBA
AMBA
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$174.1M
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$590.1M
$670.9M
Total Assets
$751.9M
$893.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBA
AMBA
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$174.1M
$90.8M
Q3 25
$142.7M
$98.2M
Q2 25
$141.3M
$100.8M
Q1 25
$144.6M
$114.3M
Q4 24
$127.1M
$169.6M
Q3 24
$153.9M
$100.1M
Q2 24
$131.8M
$68.1M
Stockholders' Equity
AMBA
AMBA
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$590.1M
$656.2M
Q3 25
$576.5M
$769.5M
Q2 25
$572.7M
$765.1M
Q1 25
$561.4M
$764.0M
Q4 24
$554.3M
$766.9M
Q3 24
$547.6M
$668.5M
Q2 24
$555.4M
$665.2M
Total Assets
AMBA
AMBA
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$751.9M
$893.5M
Q3 25
$706.4M
$999.4M
Q2 25
$701.9M
$987.0M
Q1 25
$689.0M
$966.2M
Q4 24
$670.8M
$974.8M
Q3 24
$650.3M
$926.5M
Q2 24
$638.7M
$919.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBA
AMBA
GKOS
GKOS
Operating Cash FlowLast quarter
$34.3M
Free Cash FlowOCF − Capex
$31.4M
FCF MarginFCF / Revenue
29.0%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$64.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBA
AMBA
GKOS
GKOS
Q1 26
Q4 25
$34.3M
$6.8M
Q3 25
$5.5M
$-10.1M
Q2 25
$14.8M
$7.0M
Q1 25
$25.4M
$-18.5M
Q4 24
$6.6M
$507.0K
Q3 24
$16.7M
$-9.6M
Q2 24
$-15.0M
$-18.4M
Free Cash Flow
AMBA
AMBA
GKOS
GKOS
Q1 26
Q4 25
$31.4M
$3.9M
Q3 25
$1.4M
$-11.7M
Q2 25
$10.2M
$5.8M
Q1 25
$21.2M
$-20.5M
Q4 24
$4.1M
$-1.2M
Q3 24
$14.2M
$-11.0M
Q2 24
$-16.1M
$-20.5M
FCF Margin
AMBA
AMBA
GKOS
GKOS
Q1 26
Q4 25
29.0%
2.7%
Q3 25
1.4%
-8.8%
Q2 25
11.9%
4.7%
Q1 25
25.3%
-19.2%
Q4 24
5.0%
-1.2%
Q3 24
22.2%
-11.4%
Q2 24
-29.5%
-21.4%
Capex Intensity
AMBA
AMBA
GKOS
GKOS
Q1 26
Q4 25
2.7%
2.0%
Q3 25
4.3%
1.2%
Q2 25
5.3%
0.9%
Q1 25
5.0%
1.8%
Q4 24
3.0%
1.6%
Q3 24
4.0%
1.5%
Q2 24
2.1%
2.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMBA
AMBA

TW$76.0M70%
Asia Pacific Other Than Taiwan$20.2M19%
North America Other Than United States$7.4M7%
Other$5.0M5%

GKOS
GKOS

Segment breakdown not available.

Related Comparisons